QA: Ionis Pharmaceuticals INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000874015_2015_Ionis_Pharmaceuticals_INC.pdf

Logs

warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 1.1642363942467189, 'aggregate_val': 698029000, 'exp_sum': 322529000, 'exp_to_value': {'LiabilitiesCurrent': 115332000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 207197000}}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 1.1113518197573657, 'aggregate_val': 755315000, 'exp_sum': 357740000, 'exp_to_value': {'LiabilitiesCurrent': 148876000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 208864000}}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000874015, Ionis Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 836,597,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 88,958,000
3 remainder_Assets 30,254,000
4 LiabilitiesCurrent 115,332,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 582,697,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,225,155
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 270,696,101
11 remainder_Revenues 258,051,896
12 remainder_NetIncome -3,049,889
13 remainder_ComprehensiveNetIncome -328,744
  yvar yval
0 Assets 955,809,000
1 Liabilities 698,029,000
2 Expenses 291,921,256
3 Revenues 258,051,896
4 StockholdersEquity 257,780,000
5 NetIncome -36,919,249
6 ComprehensiveNetIncome -37,083,621
7 BaseVar 1,103,594,892
8 EconomicCapitalRatiobeforeLimitedLiability 0.635
9 EconomicCapitalRatio 2.00

Edgar->Model Mapping

Feature Distribution

Change over Time